Non-GMP Manufacture: Light Path™ Discovery

15 + Years’ Experience

In assessing, optimizing and expressing biotherapeutic drug candidates.

1000+ Molecules

More than 1000 biotherapeutic drug candidates’ developability profile assessed, final leads de-risked and optimized.

1500+ Biotherapeutic Candidates

Over 1500 biotherapeutic candidate product variants expressed.

Small scale non-GMP protein production

We support both mammalian and microbial derived molecules using our proven GS System® and XS® Technologies expression platforms.

Our Light Path™ Discovery Protein Production Services include:

Gene to non-GMP production services
Offerings for both mammalian and microbial expressed proteins and antibodies
Protein production for manufacturability, safety and efficacy testing

Light Path™ Discovery Protein Production guarantees 2 grams of non-GMP material delivered in 6 weeks for standard mAbs.*

*This guarantee is only in respect of standard mAbs. The quoted timeline is from vector construction to purified product. Any guarantee of product amount and/or timeline is subject to terms and conditions

Our locations

Locations where this service is provided

Explore all locations

Cambridge, United Kingdom

Cambridge, MA, USA

Explore all locations

Related Insights

Visit Knowledge Center

Webinar (on-demand)

De-risking Your Journey to the Clinic: Overcoming Manufacturability, Expression, and Early Material...

Join Rebecca Michael, Principal Group Leader, Early Development Services at Lonza to learn how in silico and in vitro design and optimization tools...

White paper

Mitigate Immunogenicity Potential to De-risk Your Early Drug Development

Despite exciting breakthroughs in science and technology over the last couple of decades, the pharmaceutical industry continues to struggle with high...

Visit Knowledge Center